Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kelly M. McMahon"'
Autor:
Marie Locard-Paulet, Claus Jørgensen, John Sinclair, Jonathan D. Worboys, Antoinette van Weverwijk, Kelly M McMahon, Yinyin Yuan, Lindsay Lim, Clare M. Isacke, Giulia Veluscek
Publikováno v:
Science signaling. 9(414)
The exit of metastasizing tumor cells from the vasculature, extravasation, is regulated by their dynamic interactions with the endothelial cells that line the internal surface of vessels. To elucidate signals controlling tumor cell adhesion to the en
Autor:
P. Musiwaro, Milene Volpato, Yonghong Peng, Laurence H. Patterson, Roger M. Phillips, Chris W. Sutton, Kelly M. McMahon, H.Y. Chi, Krzysztof Poterlowicz, Andy J. Scally
Publikováno v:
Journal of Proteome Research. 11:2863-2875
Three dimensional multicell tumor spheroids (MCTS) provide an experimental model where the influence of microenvironmental conditions on protein expression can be determined. Sequential trypsin digestion of HT29 colon carcinoma MCTS enabled segregati
Autor:
John Sinclair, Robert Gourlay, Christopher J. Tape, Douglas J. Lamont, Jonathan D. Worboys, Douglas A. Lauffenburger, Claus Jørgensen, Matthias Trost, Kelly M McMahon, Janis Vogt
Publikováno v:
Analytical Chemistry
Reproducible, comprehensive phosphopeptide enrichment is essential for studying phosphorylation-regulated processes. Here, we describe the application of hyper-porous magnetic TiO2 and Ti-IMAC microspheres for uniform automated phosphopeptide enrichm
Autor:
George Poulogiannis, Maria Dimitriadi, Christopher J. Tape, Claus Jørgensen, Stephanie Ling, Hui S. Leong, Douglas A. Lauffenburger, Kelly M. McMahon, Ida C. Norrie, Jonathan D. Worboys, Crispin J. Miller
Publikováno v:
Cancer Research. 76:A34-A34
Pancreatic Ductal Adenocarcinoma is characterized by a reactive stroma, which modifies tumor progression and response to therapy. Oncogenic mutations regulate signaling both within tumor cells and adjacent stromal cells. However, defining whether onc
Autor:
Christopher J. Tape, Stephanie Ling, Maria Dimitriadi, Kelly M. McMahon, Jonathan D. Worboys, Hui Sun Leong, Ida C. Norrie, Crispin J. Miller, George Poulogiannis, Douglas A. Lauffenburger, Claus Jørgensen
Publikováno v:
Cell
Tape, C J, Ling, S, Dimitriadi, M, McMahon, K M, Worboys, J D, Leong, H S, Norrie, I C, Miller, C J, Poulogiannis, G, Lauffenburger, D A & Jørgensen, C 2016, ' Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation ', Cell, vol. 165, no. 7, pp. 910–920 . https://doi.org/10.1016/j.cell.2016.05.079
Tape, C J, Ling, S, Dimitriadi, M, McMahon, K M, Worboys, J, Leong, H S, Norrie, I, Miller, C, Poulogiannis, G, Lauffenburger, D A & Jorgensen, C 2016, ' Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation ', Cell, vol. 165, no. 4, pp. 910-920 . https://doi.org/10.1016/j.cell.2016.03.029
Elsevier
Tape, C J, Ling, S, Dimitriadi, M, McMahon, K M, Worboys, J D, Leong, H S, Norrie, I C, Miller, C J, Poulogiannis, G, Lauffenburger, D A & Jørgensen, C 2016, ' Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation ', Cell, vol. 165, no. 7, pp. 910–920 . https://doi.org/10.1016/j.cell.2016.05.079
Tape, C J, Ling, S, Dimitriadi, M, McMahon, K M, Worboys, J, Leong, H S, Norrie, I, Miller, C, Poulogiannis, G, Lauffenburger, D A & Jorgensen, C 2016, ' Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation ', Cell, vol. 165, no. 4, pp. 910-920 . https://doi.org/10.1016/j.cell.2016.03.029
Elsevier
Oncogenic mutations regulate signaling within both tumor cells and adjacent stromal cells. Here, we show that oncogenic KRAS (KRAS[superscript G12D]) also regulates tumor cell signaling via stromal cells. By combining cell-specific proteome labeling
Publikováno v:
Cancer Research. 71:4872-4872
Hypoxia is a well established target for anticancer therapy. Within the tumor microenvironment, hypoxia does not reside alone; instead it exists in combination with multiple other pathophysiological features. The occurrence of these features in combi
Publikováno v:
Cancer Research. 70:4571-4571
Introduction Hypoxia is a well established target for anticancer therapy. Within the tumor microenvironment, hypoxia does not reside alone; instead it exists in combination with multiple other physiological/biochemical changes. The occurrence of thes